These Are the Top Pediatric Care Providers in Westchester

Image
vaccine finder near me :: Article Creator Where Can I Find The New COVID Vaccine Near Me? - KQED Where Can I Find the New COVID Vaccine Near Me?KQEDKQEDSave ArticleKQEDKQED News News Daily Newsletter Stay on top of what's happening in the Bay Area with essential Bay Area news stories, sent to your inbox every weekday. Podcasts & Radio Hyphenación Where conversation and cultura meet. Video & TV Meredith's Must-Sees See Senior Director of TV Programming Meredith Speight's recommendations from this month's KQED 9, PLUS and Passport schedules. Events Videos from KQED Live Watch recordings of recent KQED Live events. Support KQED Donor-Advised Funds Support KQED by using your donor-advised fund to make a charitable gift. Featured ...

Russia may start mass vaccination by year's end - Anadolu Agency

MOSCOW

Russian president Thursday said he expects mass vaccination against coronavirus to start in the country by the end of the year. 

Speaking at the VTB Capital Russia Calling! Investment Forum in Moscow, Vladimir Putin said the vaccine has already been delivered to all Russian regions.

"All regions have received the vaccine. I hope that we will be able to start mass vaccination at the end of the year. Our first partner to receive this vaccine is Belarus," he said.

Putin stressed that main requirements of the coronavirus vaccines are efficiency and safety and that both Russian vaccines meet these conditions. He also announced that the third vaccine will be registered soon.

On Aug. 11, Russia issued a temporary conditional registration to a coronavirus vaccine developed by the Gamaleya Research Institute of Epidemiology and Microbiology.

This kind of registration is issued for medicines which are vital to protect the public health in an emergency such as the coronavirus pandemic.

The Russian coronavirus vaccine, named as Gam-COVID-Vac (Gamaleya COVID Vaccine) by the developers and with the trade name Sputnik V (V for the vaccine), has a valid registration until Jan. 1, 2021 and will undergo a third phase of trials involving up to 40,000 people as well as post-clinical research.

On Oct. 14, Putin said that a second coronavirus vaccine was granted regulatory approval. He said the vaccine, EpiVakKorona, was registered at the Vector State Research Center in Novosibirsk. 

Anadolu Agency website contains only a portion of the news stories offered to subscribers in the AA News Broadcasting System (HAS), and in summarized form. Please contact us for subscription options.

Comments

Popular posts from this blog

Primary Care - North Greece Internal Medicine & Pediatrics

180+ chief medical officers to know | 2025

Screening and Testing for Hepatitis B Virus Infection ...